查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532518

甲状腺消融设备市场- 按类型（射频消融、微波消融）、产品（热、非热）、应用（甲状腺癌、甲状腺结节）、最终用途（医院、ASC、癌症专科中心） - 全球预测（2024 年） - 2032)

Thyroid Ablation Devices Market - By Type (Radiofrequency Ablation, Microwave Ablation), Product (Thermal, Non-thermal), Application (Thyroid Cancer, Thyroid Nodules), End-use (Hospitals, ASCs, Cancer Specialty Centers) - Global Forecast (2024 - 2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 99 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于领先公司获得 FDA 许可的数量不断增加，2024 年至 2032 年间，全球甲状腺消融设备市场的复合年增长率将达到 9.9%。甲状腺消融是一种用于治疗甲状腺结节和癌症的微创手术，与传统手术相比，因其有效性和缩短的恢復时间而受到广泛关注。 FDA 的批准标誌着高水准的安全性和有效性，增强了医疗保健提供者和患者的信心。随着领先公司获得更多批准，他们可以将先进的创新设备推向市场，进一步推动采用。

例如，2023 年 11 月，Baird Medical 的微波消融系统获得 FDA 批准，该系统是专为切除甲状腺结节而设计的装置。该公司执行长预计这项创新技术在美国的潜在市场规模将达到 16 亿美元。

甲状腺疾病的盛行率不断增加，加上对侵入性较小的治疗方案的渴望，正在推动甲状腺消融设备市场的成长。科技的进步和人们对消融手术益处的认识不断提高，导致需求不断增长。这一趋势反映了甲状腺疾病管理中向先进、以患者为中心的解决方案的更广泛转变。

甲状腺消融设备产业的整体价值根据类型、产品、应用、最终用户和地区进行分类。

根据类型，微波消融领域的甲状腺消融设备市场收入从2024 年到2032 年将实现令人称讚的复合年增长率。 。该技术利用微波能量精确瞄准并破坏异常组织，从而缩短恢復时间并减少併发症。微波消融的好处，包括其有效性和较低的风险状况，已导致医疗保健提供者和患者越来越多地采用微波消融。随着人们对这些优势的认识不断增强以及技术不断进步，甲状腺消融设备（尤其是利用微波技术的设备）的市场正在显着扩大。

就产品而言，从 2024 年到 2032 年，基于非热的设备领域将出现显着增长。这些方法提供精确且受控的消融，降低併发症的风险并改善患者的治疗效果。随着医疗保健专业人员和患者寻求具有更好安全性的侵入性较小的选择，非热基设备越来越受欢迎。它们以最小的不适和更快的恢復时间有效地靶向甲状腺结节，正在推动市场成长并扩大甲状腺消融领域的治疗选择。

欧洲甲状腺消融设备市场从2024 年到2032 年将呈现显着的复合年增长率。缩短恢復时间并降低风险。甲状腺疾病的日益流行和向以患者为中心的护理的转变正在推动这一趋势。此外，欧洲监管部门的批准和创新疗法的医疗保健资金进一步推动了市场成长。随着欧洲的医疗保健提供者和患者寻求高效、侵入性较小的治疗方法，甲状腺消融设备市场正在该地区迅速扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 甲状腺癌和甲状腺结节盛行率上升
      • 微创手术日益受到青睐
      • 消融设备的技术进步
      • 提高认识和筛检计划
    • 产业陷阱与挑战
      • 甲状腺消融设备成本高
      • 缺乏熟练的专业人员
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场估计与预测：按类型，2021 - 2032

  • 主要趋势
  • 射频消融术
  • 微波消融
  • 其他类型

第 6 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 基于热的设备
  • 非热基设备

第 7 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 甲状腺癌
  • 甲状腺结节

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 癌症专科中心
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BVM Medical Limited
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MedWaves, Inc.
  • Olympus Corporation
  • STARmed Co., Ltd.
  • Stryker Corporation
  • Terumo Corporation
  • Theraclion SA
简介目录
Product Code: 9576

Global Thyroid Ablation Devices Market will witness a 9.9% CAGR between 2024 and 2032 due to the increasing number of FDA clearances granted to leading companies. Thyroid ablation, a minimally invasive procedure used to treat thyroid nodules and cancer, has gained significant attention for its effectiveness and reduced recovery times compared to traditional surgery. FDA clearances signal a high level of safety and efficacy, boosting confidence among healthcare providers and patients. As leading companies receive more approvals, they can bring advanced and innovative devices to market, further driving adoption.

For instance, in November 2023, Baird Medical received FDA clearance for its microwave ablation system, a device designed for the removal of thyroid nodules. The company's CEO anticipated a potential market size of $1.6 billion in the U.S. for this innovative technology.

The increasing prevalence of thyroid disorders, coupled with the desire for less invasive treatment options, is fueling the growth of the thyroid ablation devices market. Enhanced technology and growing awareness about the benefits of ablation procedures contribute to rising demand. This trend reflects a broader shift towards advanced, patient-centric solutions in the management of thyroid conditions.

The overall Thyroid Ablation Devices Industry value is classified based on the type, product, application, end-user, and region.

Based on type, the thyroid ablation devices market revenue from the microwave ablation segment will register a commendable CAGR from 2024 to 2032. Microwave ablation offers a minimally invasive alternative to traditional surgical methods for treating thyroid nodules and tumors. This technique uses microwave energy to precisely target and destroy abnormal tissue, resulting in reduced recovery times and fewer complications. The benefits of microwave ablation, including its effectiveness and lower risk profile, have led to growing adoption among healthcare providers and patients. As awareness of these advantages spreads and technology improves, the market for thyroid ablation devices, particularly those utilizing microwave technology, is expanding significantly.

In terms of product, the nonthermal-based devices segment will witness an appreciable growth from 2024 to 2032. Non-thermal techniques, such as radiofrequency ablation and cryoablation, offer alternative methods that minimize heat damage to surrounding tissues. These methods provide precise and controlled ablation, reducing the risk of complications and improving patient outcomes. As healthcare professionals and patients seek less invasive options with better safety profiles, non-thermal-based devices are gaining popularity. Their effectiveness in targeting thyroid nodules with minimal discomfort and faster recovery times is driving market growth and expanding treatment options in the thyroid ablation sector.

Europe thyroid ablation devices market will exhibit a notable CAGR from 2024 to 2032. European healthcare systems are prioritizing advanced technologies that offer effective solutions for managing thyroid conditions with reduced recovery times and lower risks compared to traditional surgery. The growing prevalence of thyroid disorders and a shift towards patient-centric care are driving this trend. Additionally, European regulatory approvals and healthcare funding for innovative treatments further boost market growth. As healthcare providers and patients in Europe seek efficient, less invasive therapies, the thyroid ablation devices market is expanding rapidly in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of thyroid cancer & thyroid nodules
      • 3.2.1.2 Growing preference for minimally invasive surgeries
      • 3.2.1.3 Technological advancements in ablation devices
      • 3.2.1.4 Increasing awareness and screening programs
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of thyroid ablation devices
      • 3.2.2.2 Lack of skilled professionals
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Radiofrequency ablation
  • 5.3 Microwave ablation
  • 5.4 Other types

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Thermal based devices
  • 6.3 Non-thermal based devices

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Thyroid cancer
  • 7.3 Thyroid nodules

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Cancer specialty centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AngioDynamics, Inc.
  • 10.2 Boston Scientific Corporation
  • 10.3 BVM Medical Limited
  • 10.4 Integra Lifesciences Holdings Corporation
  • 10.5 Johnson & Johnson
  • 10.6 Medtronic plc
  • 10.7 MedWaves, Inc.
  • 10.8 Olympus Corporation
  • 10.9 STARmed Co., Ltd.
  • 10.10 Stryker Corporation
  • 10.11 Terumo Corporation
  • 10.12 Theraclion SA